Trial Profile
Three Month Efficacy and Safety Study of a Fixed Combination of Brinzolamide 1%/Brimonidine 0.2% Compared to Brinzolamide 1% and Brimonidine 0.2% All Dosed Three Times Daily in Patients With Open-Angle Glaucoma and/or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2014
Price :
$35
*
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Brimonidine; Brinzolamide
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 01 Nov 2014 New trial record